# EDGAR Filing Document

**Accession Number:** 0002075192
**File Stem:** 9999999997-25-002926
**Filing Date:** 2025-7
**Character Count:** 1171
**Document Hash:** 5de51e94864a04867ac8ceb53bdfedd3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999997-25-002926.hdr.sgml**: 20250707

**ACCESSION NUMBER**: 9999999997-25-002926

**CONFORMED SUBMISSION TYPE**: SEC STAFF LETTER

**CATEGORY**: SERIOUS DEFICIENCIES

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250707

**ACTION DATE**: 20250707

**RECEIVED DATE**: 20250707

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Top Create Biotech Co., Ltd.
- **CENTRAL INDEX KEY:** 0002075192
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1230

**FILING VALUES:**
- **FORM TYPE:** SEC STAFF LETTER

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 89 NEXUS WAY, CAMANA BAY
- **CITY:** GRAND CAYMAN
- **PROVINCE COUNTRY:** E9
- **ZIP:** KY1-9009
- **BUSINESS PHONE:** 8613392064846

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 89 NEXUS WAY, CAMANA BAY
- **CITY:** GRAND CAYMAN
- **PROVINCE COUNTRY:** E9
- **ZIP:** KY1-9009

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._